Northwestern University Feinberg School of Medicine scientists are pursing groundbreaking research on reproductive health as well sex differences in disease incidence and treatment. Read on for some of the latest women’s health news, including pregnancy, breast cancer, heart disease and behavioral health.
A new combination therapy targeting breast cancer tumors in the brain dramatically decreased tumor size and increased survival in mice, according to a new study.
A new patient-centered decision support tool aims to help pregnant women decide whether they prefer trial-of-labor or a repeat cesarean delivery after having a prior cesarean.
Machine-learning technology could help pathologists more accurately assess how a patient’s immune system is responding to breast cancer, according to a recent series of reports authored in part by Feinberg faculty.
A recent Northwestern Medicine study has identified that a transcription factor protein called AP-1 regulates gene enhancers that may be responsible for promoting the development of uterine fibroids.
Elagolix, a newly developed orally administered drug, was effective in reducing heavy menstrual bleeding in women with uterine fibroids, according to a recent Northwestern Medicine clinical trial.
The second annual Women in Medicine symposium brought together Northwestern educators, scientists, trainees and students to highlight pioneering women and challenges still faced today.
In a surprising new finding, radiation combined with chemotherapy did not increase recurrence-free survival in women with stage III/IVA endometrial cancer following surgery.
A gene involved in male hormone production plays a major role in the development of polycystic ovary syndrome, according to a recent study.
A drug called niraparib showed clinically relevant activity in women with relapsed ovarian cancer who had exhausted all previous treatment options, according to a recent study.
Northwestern investigators are building a multi-disciplinary enterprise that is making critical discoveries in maternal-fetal health, with significant clinical implications and real-world consequences.